Richard Scott Struthers - Net Worth and Insider Trading
Richard Scott Struthers Net Worth
The estimated net worth of Richard Scott Struthers is at least $67 Million dollars as of 2024-11-05. Richard Scott Struthers is the President & CEO of Crinetics Pharmaceuticals Inc and owns about 1,159,290 shares of Crinetics Pharmaceuticals Inc (CRNX) stock worth over $67 Million. Details can be seen in Richard Scott Struthers's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Richard Scott Struthers has not made any transactions after 2024-05-08 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Richard Scott Struthers
Richard Scott Struthers Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Richard Scott Struthers owns 1 companies in total, including Crinetics Pharmaceuticals Inc (CRNX) .
Click here to see the complete history of Richard Scott Struthers’s form 4 insider trades.
Insider Ownership Summary of Richard Scott Struthers
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CRNX | Crinetics Pharmaceuticals Inc | 2024-05-08 | director & See Remarks |
Richard Scott Struthers Latest Holdings Summary
Richard Scott Struthers currently owns a total of 1 stock. Richard Scott Struthers owns 1,159,290 shares of Crinetics Pharmaceuticals Inc (CRNX) as of May 8, 2024, with a value of $67 Million.
Latest Holdings of Richard Scott Struthers
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CRNX | Crinetics Pharmaceuticals Inc | 2024-05-08 | 1,159,290 | 57.81 | 67,018,555 |
Holding Weightings of Richard Scott Struthers
Richard Scott Struthers Form 4 Trading Tracker
According to the SEC Form 4 filings, Richard Scott Struthers has made a total of 10 transactions in Crinetics Pharmaceuticals Inc (CRNX) over the past 5 years, including 1 buys and 9 sells. The most-recent trade in Crinetics Pharmaceuticals Inc is the sale of 107,448 shares on May 8, 2024, which brought Richard Scott Struthers around $5 Million.
Insider Trading History of Richard Scott Struthers
- 1
Richard Scott Struthers Trading Performance
GuruFocus tracks the stock performance after each of Richard Scott Struthers's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Richard Scott Struthers is 19.17%. GuruFocus also compares Richard Scott Struthers's trading performance to market benchmark return within the same time period. The performance of stocks bought by Richard Scott Struthers within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Richard Scott Struthers's insider trading performs compared to the benchmark.
Performance of Richard Scott Struthers
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 8.21 | | | | | |
| Relative Return to S&P 500(%) | 5.77 | | | | | |
Richard Scott Struthers Ownership Network
Ownership Network List of Richard Scott Struthers
Ownership Network Relation of Richard Scott Struthers
Richard Scott Struthers Owned Company Details
What does Crinetics Pharmaceuticals Inc do?
Who are the key executives at Crinetics Pharmaceuticals Inc?
Richard Scott Struthers is the director & See Remarks of Crinetics Pharmaceuticals Inc. Other key executives at Crinetics Pharmaceuticals Inc include Chief Development Officer Dana Pizzuti , See Remarks Marc Wilson , and Chief Scientific Officer Stephen F. Betz .
Crinetics Pharmaceuticals Inc (CRNX) Insider Trades Summary
Over the past 18 months, Richard Scott Struthers made 5 insider transaction in Crinetics Pharmaceuticals Inc (CRNX) with a net sale of 448,399. Other recent insider transactions involving Crinetics Pharmaceuticals Inc (CRNX) include a net sale of 40,035 shares made by Stephen F. Betz , a net sale of 159,049 shares made by Marc Wilson , and a net sale of 91,672 shares made by Dana Pizzuti .
In summary, during the past 3 months, insiders sold 46,410 shares of Crinetics Pharmaceuticals Inc (CRNX) in total and bought 0 shares, with a net sale of 46,410 shares. During the past 18 months, 913,970 shares of Crinetics Pharmaceuticals Inc (CRNX) were sold and 5,000 shares were bought by its insiders, resulting in a net sale of 908,970 shares.
Crinetics Pharmaceuticals Inc (CRNX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Crinetics Pharmaceuticals Inc Insider Transactions
Richard Scott Struthers Mailing Address
Above is the net worth, insider trading, and ownership report for Richard Scott Struthers. You might contact Richard Scott Struthers via mailing address: C/o Crinetics Pharmaceuticals, Inc., 10222 Barnes Canyon Road, Bldg. #2, San Diego Ca 92121.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
